Yurdaydin, Cihan

Publishing since 1992 (Senior)

Has published 65 publications in 18 years

Number of publications published per year by Yurdaydin, Cihan. (Source : PubMed)

Distribution of publications types for Yurdaydin, Cihan. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.  Liver Int.  2009  
•  Mizrak D, Engin B, Onder FO, Yener B, Bektaş M, Biyikli Z, Idilman R, Cinar K, Karayalçin K, Ersöz S, Karayalçin S, Ozden A, Yurdaydin C, Yazihan N, Ataoğlu H, Bozkaya H, Uzunalimoğlu O. Aflatoxin exposure in viral hepatitis patients in Turkey.  Turk J Gastroenterol  2009;20;3  
•  Bektaş M, Dökmeci A, Cinar K, Halici I, Oztas E, Karayalcin S, Idilman R, Sarioglu M, Ustun Y, Nazligul Y, Ormeci N, Ozkan H, Bozkaya H, Yurdaydin C. Endoscopic Management of Biliary Parasitic Diseases.  Dig. Dis. Sci.  2009  
•  Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J, Popescu M, Hadziyannis S. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.  Gastroenterology  2009;136;7  
•  Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Luo K, Wang Y, Hadziyannis S, Wolf E, McCloud P, Batrla R, Marcellin P. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.  Hepatology  2009;49;4  
•  Idilman R, Kaymakoglu S, Oguz Onder F, Ahishali E, Bektas M, Cinar K, Pinarbasi B, Karayalcin S, Badur S, Cakaloglu Y, Mithat Bozdayi A, Bozkaya H, Okten A, Yurdaydin C. A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients.  J. Viral Hepat.  2009;16;4  
•  Karaaslan H, Yurdaydin C. Viral hepatitis at the Black Sea region: the problem of viral hepatitis in Turkey revisited.  Turk J Gastroenterol  2009;20;1  
•  Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H, Tuncer C, Suleymanlar I, Ovunc O, Hilmioglu F, Aslan S, Turkdogan K, Bahcecioglu HI, Yurdaydin C. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.  J. Clin. Gastroenterol.  2009;43;1  
•  Koytak ES, Mizrak D, Bektaş M, Verdi H, Arslan Ergül A, Idilman R, Cinar K, Yurdaydin C, Ersõz S, Karayalçin K, Uzunalimoğlu O, Bozkaya H. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.  Turk J Gastroenterol  2008;19;4  
•  Sherman M, Yurdaydin C, Simsek H, Silva M, Liaw YF, Rustgi VK, Sette H, Tsai N, Tenney DJ, Vaughan J, Kreter B, Hindes R. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.  Hepatology  2008;48;1  

[ See timeline ] [ See all publications ]